Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.190
+0.170 (8.42%)
At close: Jul 30, 2026, 4:00 PM EDT
2.150
-0.040 (-1.83%)
After-hours: Jul 30, 2026, 4:10 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $393.17 million as of July 30, 2026. Its market cap has increased by 681.26% in one year.
Market Cap
393.17M
Enterprise Value
298.28M
1-Year Change
681.26%
Ranking
Category
Stock Price
$2.19
ChartMarket Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $393.17M, a decrease of -62.59%. That is a compound annual growth rate of -17.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 393.17M | 352.66% |
| Dec 31, 2025 | 86.86M | 1.14% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 386.42M |
| Capricor Therapeutics | 386.27M |
| Larimar Therapeutics | 378.91M |
| X4 Pharmaceuticals | 377.28M |
| Atea Pharmaceuticals | 369.73M |
| Enanta Pharmaceuticals | 362.03M |
| Abeona Therapeutics | 355.08M |
| Compass Therapeutics | 349.37M |